BioCryst Pharmaceuticals | BCRX - Market Capitalization


BioCryst Pharmaceuticals reported $2.06B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Chugai Pharma JPY 12.65T 1.81T Jun/2026
DBV Technologies USD 1.23B 327M Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Incyte USD 22.65B 3.92B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026